Latest other current assets for LEGN: $34M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Legend Biotech (LEGN) currently reports a other current assets of $34M as of September 2026. That compares with $220M in the prior-year period — down 84.7% year over year. Use the charts on this page to explore Legend Biotech's other current assets history and peer comparisons.
Legend Biotech's other current assets decreased from $220M to $34M — a 84.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Legend Biotech reported $34M in other current assets as of September 2026. That compares with $220M in the prior-year period — down 84.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Legend Biotech, and consider following LEGN for alerts when major investors trade the stock.
Legend Biotech is classified in the Healthcare sector. On other current assets, it currently shows $34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEGN with unrelated industries.